What was filed
The complaint is Document 1 in Cure CMT v. Hereditary Neuropathy Foundation, Inc., No. 1:26-cv-11291 (N.D. Ill., Eastern Division), filed September 15, 2026. It runs 12 pages, and the docket notes a jury demand. The docket shows the case randomly assigned to Judge Matthew F. Kennelly, with Magistrate Judge Jeannice W. Appenteng designated. On information and belief, the complaint describes the defendant as a New York 501(c)(3) not-for-profit corporation.
The mark
The complaint says Cure CMT has used CURE CMT since April 2025 for charity and advocacy work related to Charcot-Marie-Tooth disease and owns Reg. No. 7,789,295 for CURE CMT for charitable fundraising and charitable foundation services in Class 36. USPTO TSDR lists the registration as issued May 6, 2025 and owned by CURE CMT.
What the complaint alleges
The complaint alleges, on information and belief, that the defendant operated as Hereditary Neuropathy Foundation and HNF from around 2001. It alleges that on August 31, 2026 the defendant announced a new name, logo, and website, CureCMT at curecmt.org, and that another organization in the CMT community immediately asked Cure CMT whether it was now affiliated with the defendant. It alleges that Cure CMT demanded the same day that the defendant stop, and that the defendant refused, citing its ownership of the curecmt.org domain. On information and belief, it alleges the defendant had never used CureCMT as a trademark before August 2026.
Claims and relief
The four counts are infringement under 15 U.S.C. § 1114, false designation of origin under 15 U.S.C. § 1125(a), violation of the Illinois Uniform Deceptive Trade Practices Act, and Illinois common law unfair competition. The docket shows an order on a motion to extend the time to answer entered October 27, 2026.